Results for:(43 found)
Feb 4, 2014 4:27PM on Top StocksBy MSN Money Partner

Instead of racing against each other, the companies are banding together to fight diabetes, arthritis and Alzheimer's.

Jan 14, 2014 4:23PM on Top StocksBy StreetAuthority

A revolutionary approach to cancer fighting has the medical community buzzing. Here's how to profit.

Oct 28, 2013 6:30AM on Top StocksBy Benzinga

This week's highlights include quarterly reports from the two biggest companies by market capitalization, Apple and Exxon Mobil, which are expect to post declining earnings.

Sep 16, 2013 11:57AM on Top StocksBy MSN Money Partner

Under Armour is downgraded to 'neutral,' and Bristol-Myers is upgraded to 'overweight.'

Aug 14, 2013 4:00PM on Top StocksBy Benzinga

Many factors affect innovations from the pharmaceutical sector.

Jun 28, 2013 3:11PM on Top StocksBy Benzinga

Some firms believe it's the upcoming, lucrative product in cardiology care.

Jun 10, 2013 12:13PM on Top StocksBy Benzinga

The deal provides access to a lucrative respiratory drug market as the company seeks to rebuild its pipeline.

Jun 4, 2013 11:58AM on Top StocksBy MoneyShow.com

Investors with an appetite for international exposure can find exciting opportunities in sectors as diverse as insurance, pharma and media.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More